Works matching DE "MULTIPLE myeloma"


Results: 5000
    1
    2
    3

    Toxicity of CAR T-Cell Therapy for Multiple Myeloma.

    Published in:
    Acta Haematologica, 2025, v. 148, n. 3, p. 300, doi. 10.1159/000539134
    By:
    • Afrough, Aimaz;
    • Abraham, Pearl Rajan;
    • Turer, Laura;
    • Kaur, Gurbakhash;
    • Sannareddy, Aishwarya;
    • Hansen, Doris K.;
    • Anderson Jr., Larry D.
    Publication type:
    Article
    4
    5
    6

    Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab‐, Elotuzumab‐, and Carfilzomib‐Based Triplet Regimens: A Multicenter Real‐World Analysis of 635 Patients.

    Published in:
    European Journal of Haematology, 2025, v. 115, n. 1, p. 16, doi. 10.1111/ejh.14413
    By:
    • Morabito, Fortunato;
    • Martino, Enrica Antonia;
    • Galli, Monica;
    • Offidani, Massimo;
    • Zambello, Renato;
    • Bringhen, Sara;
    • Giuliani, Nicola;
    • Califano, Catello;
    • Brunori, Marino;
    • Gagliardi, Alfredo;
    • Sgherza, Nicola;
    • Quinto, Angela Maria;
    • Barilà, Gregorio;
    • Belotti, Angelo;
    • Cerchione, Claudio;
    • Casaluci, Gloria Margiotta;
    • Fontana, Raffaele;
    • Bongarzoni, Velia;
    • Tarantini, Giuseppe;
    • Derudas, Daniele
    Publication type:
    Article
    7
    8
    9

    Iberdomide, ixazomib and dexamethasone in elderly patients with multiple myeloma at first relapse.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 5, p. 1366, doi. 10.1111/bjh.19978
    By:
    • Touzeau, Cyrille;
    • Leleu, Xavier;
    • Tiab, Mourad;
    • Macro, Margaret;
    • Perrot, Aurore;
    • Gay, Julie;
    • Chateleix, Carine;
    • Moreau, Stéphane;
    • Karlin, Lionel;
    • Jacquet, Caroline;
    • Manier, Salomon;
    • Hulin, Cyrille;
    • Decaux, Olivier;
    • Richez, Valentine;
    • Chalopin, Thomas;
    • Mohty, Mohamad;
    • Orsini‐Piocelle, Frédérique;
    • Caillot, Denis;
    • Sonntag, Cécile;
    • Vignon, Marguerite
    Publication type:
    Article
    11
    13
    14

    Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain.

    Published in:
    Oncology & Therapy, 2025, v. 13, n. 2, p. 381, doi. 10.1007/s40487-025-00333-7
    By:
    • Encinas, Cristina;
    • Lozano, Virginia;
    • Hlavacek, Patrick;
    • Llinares, Julia;
    • Toribio-Castelló, Sofía;
    • Carcedo, David;
    • Asís-Montalt, Jordi;
    • Martínez-López, Joaquín
    Publication type:
    Article
    15
    16
    17

    Predicting progression events in multiple myeloma from routine blood work.

    Published in:
    NPJ Digital Medicine, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s41746-025-01636-9
    By:
    • Ferle, Maximilian;
    • Grieb, Nora;
    • Kreuz, Markus;
    • Ader, Jonas;
    • Goldschmidt, Hartmut;
    • Mai, Elias K.;
    • Bertsch, Uta;
    • Platzbecker, Uwe;
    • Neumuth, Thomas;
    • Reiche, Kristin;
    • Oeser, Alexander;
    • Merz, Maximilian
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Epidemiology and approaches for management of relapsed and refractory multiple myeloma in Gulf Countries: a narrative review and insights from the Gulf multiple myeloma experts.

    Published in:
    Current Medical Research & Opinion, 2025, v. 41, n. 4, p. 593, doi. 10.1080/03007995.2025.2502125
    By:
    • Alhuraiji, Ahmad;
    • Lal, Amar;
    • Al Mehairi, Amna;
    • Alam, Arif;
    • Mudawi, Deena;
    • Khan, Faraz;
    • Al Nabhani, Ibrahim;
    • El-Najjar, Inas;
    • AL-farsi, Khalil;
    • K Rana, Shabeeha;
    • Wagdy, Tharwat;
    • Yassin, Mohamed A.;
    • Rodríguez Otero, Paula;
    • Haddadin, Haya;
    • Aljabban, Ali
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50